FLNA
Filana Therapeutics, Inc.
0.7395$
+1.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Filana Therapeutics, Inc. (FLNA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/18/2026 | Current report (8-K) | FILANA THERAPEUTICS, INC. (FLNA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 07/29/2026 | Current report (8-K) | FILANA THERAPEUTICS, INC. (FLNA): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.